BioMedPartners

Basel, Switzerland
Early to mid stage life sciences-focused VC firm investing in geographies such as Europe

About BioMedPartners

BioMedPartners is a Financial Services company based in Basel (Switzerland). Early to mid stage life sciences-focused VC firm investing in geographies such as Europe. It operates on a B2B model. Its focus areas include Investment Industry, Venture Capital Funds, Independent Funds and Conventional VCs.

Company details

Investments are directed by BioMedPartners toward early to mid-stage companies in the life sciences sector, including diagnostics, biopharma, medical devices, and biotech. Operations center on European geographies, with typical commitments ranging from CHF2 million to CHF10 million per company. Assets under management total CHF320 million. Notable portfolio inclusions encompass Effector Therapeutics, Amplyx Pharmaceuticals, NanoString Technologies, and Affimed Therapeutics. The firm is based in Basel, Switzerland.

  • Headquarters Basel, Switzerland
  • Sectors
    Financial Services
  • Website biomedvc.com

People of BioMedPartners

10 people are tracked at BioMedPartners (3 in leadership, 7 in board & advisors).

NameRoleGroup
Thomas Möller
General PartnerLeadership
Michael Wacker
General PartnerLeadership
Markus Hosang
General PartnerLeadership
Ulrich Geilinger
Member advisory boardBoard & advisors
Andrea Pfeifer
Chairwoman of the boardBoard & advisors
William M. Burns
Senior business & scientific advisorBoard & advisors
Ulrich Vischer
Board memberBoard & advisors
Adam Cohen
Scientific AdvisorBoard & advisors
H.c. Henri B. Meier
Chairman of the boardBoard & advisors
Bernard Burkhalter
Member of the boardBoard & advisors
Premium access

Complete people profiles for BioMedPartners

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Biomedpartners

Premium access

Complete news archive for BioMedPartners

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BioMedPartners

BioMedPartners is headquartered in Basel, Switzerland. It is registered at Basel, Basel-stadt, Switzerland.

Investments are directed by BioMedPartners toward early to mid-stage companies in the life sciences sector, including diagnostics, biopharma, medical devices, and biotech. Operations center on European geographies, with typical commitments ranging from CHF2 million to CHF10 million per company. Assets under management total CHF320 million. Notable portfolio inclusions encompass Effector Therapeutics, Amplyx Pharmaceuticals, NanoString Technologies, and Affimed Therapeutics. The firm is based in Basel, Switzerland.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available